PCP
TWST icon

Perbak Capital Partners’s Twist Bioscience TWST Stock Holding History

Perbak Capital Partners’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-46,415
Closed -$1.31M – 316
2025
Q3 		$1.31M Buy
46,415
+22,805
+97% +$691K 0.23% 83
2025
Q2 		$869K Buy
+23,610
New +$816K 0.2% 58

Other funds holding TWST

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

Perbak Capital Partners's TWST Position: Q4 2025 in Review

Perbak Capital Partners sold out of Twist Bioscience (TWST) in Q4 2025, closing a stake of 46,415 shares — an estimated $1.31M sold.

Perbak Capital Partners first reported a position in TWST in Q2 2025 and held it in 2 quarters. The position peaked at $1.31M in Q3 2025. 243 funds tracked by Wall St. Rank hold TWST as of Q4 2025.

  • Perbak Capital Partners reported no remaining Twist Bioscience position as of Q4 2025 after selling out during the quarter.
  • Perbak Capital Partners sold 46,415 Twist Bioscience shares in Q4 2025, an estimated $1.31M.
  • Perbak Capital Partners first reported a position in Twist Bioscience in Q2 2025 and held it in 2 quarters.
  • Perbak Capital Partners's Twist Bioscience position peaked at $1.31M in Q3 2025.
  • 243 funds tracked by Wall St. Rank held Twist Bioscience as of Q4 2025.

Based on Perbak Capital Partners's 13F filing for Q4 2025, filed 17 Feb 2026.